VYNE Therapeutics Inc. (VYNE)

VYNE Therapeutics Revenue

VYNE Therapeutics had revenue of $86.00K in the quarter ending March 31, 2026, a decrease of -57.43%. This brings the company's revenue in the last twelve months to $454.00K, down -24.96% year-over-year. In the year 2025, VYNE Therapeutics had annual revenue of $570.00K with 13.77% growth.

• Revenue (ttm): $454.00K
• Revenue Growth: -24.96%
• P/S Ratio: 49.76
• Revenue / Employee: $45,400
• Employees: 10
• Market Cap: 22.59M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	570.00K	69.00K	13.77%
Dec 31, 2024	501.00K	77.00K	18.16%
Dec 31, 2023	424.00K	-53.00K	-11.11%
Dec 31, 2022	477.00K	-454.00K	-48.76%
Dec 31, 2021	931.00K	-20.06M	-95.57%
Dec 31, 2020	20.99M	20.55M	4,638.83%
Dec 31, 2019	443.00K	-3.15M	-87.68%
Dec 31, 2018	3.60M	-987.00K	-21.54%
Dec 31, 2017	4.58M	3.91M	579.82%
Dec 31, 2016	674.00K	-	-
Dec 31, 2015	-	-	-

Data Source: Fiscal.ai Last updated: May 15, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 21, 2026

Data Sources Report a data error